长读测序市场 - 2017-2027年全球行业规模、份额、趋势、机会和预测，按组件、技术、工作流程、应用、终端用户、公司和地区划分

全球长读测序市场预计将在2023-2027年预测期内出现令人印象深刻的增长。主要因素包括遗传性疾病的发生率越来越高，政府对研发活动的支持越来越多，以及技术的广泛发展正在推动市场的增长。长读测序，也被称为第三代测序，是一种正在研究的DNA测序技术。它可以一次确定10,000到100,000个碱基对之间的长序列DNA的核苷酸序列。这项技术消除了其他DNA测序方法中通常需要的切割和然后扩增DNA的需要。支持市场增长的其他因素有：研发活动的增加，包括癌症在内的遗传病患者数量的增加，临床试验数量的增加，个性化医疗的普及，现代医疗诊断方法的接受度的增加，医疗机构出于学术目的对序列分析方法的使用增加，世界人口的增加，无机增长战略的采用增加，以及新兴子市场的巨大潜力。

遗传性疾病发病率的上升

遗传性疾病，如色盲、唐氏综合症、囊性纤维化等，在全球范围内的发病率越来越高，这促进了市场的增长。根据世界卫生组织（WHO）的数据，超过10,000种疾病是已知的单基因疾病，由人类DNA中的一个单一基因错误引发的。在长线测序方法的帮助下，病人的整个基因组学可以得到检查。因此，在治疗遗传病方面，长读测序的采用率上升了。患有遗传病的病人越来越多，也是促进市场增长的一个因素。根据世界卫生组织（WHO）的数据，镰刀型细胞贫血症是一种严重的遗传病，影响到大约72000名新生儿。

政府对研发活动的支持不断增加

使用长读测序方法的研究越来越多，受到政府当局的大力资助，这是市场增长的一个关键原因。此外，研究活动数量的增加也促进了市场的增长。例如，在美国，基因组学研究和开发项目是通过美国国家卫生研究院（NIH）以及全球众多其他团体资助的。目前，大量的研究活动正在进行，预计这将使制造商在开发新的和先进的长读测序时具有优势，并为长读测序市场带来许多机会。例如，在美国，基因组学研究和开发项目是通过美国国家卫生研究院（NIH）以及全球各地的许多其他团体资助的。

技术进步

测序仪技术进步的兴起正在推动市场的增长。这些进步使测序更加高效、准确和便携。例如，SMRT测序仪产生的长读数跨越了可能的重复区域，并提供了整个基因组的全面视图。同样，在2018年，加州太平洋生物科学公司（PacBio）宣布加强他们的Sequel系统，其中包括新版本的软件，新的消耗品，包括试剂和新的SMRT细胞（1M v3）。

可用的定制产品

利用给定的市场数据，TechSci Research根据公司的具体需要提供定制服务。该报告有以下定制选项：

公司信息

• 其他市场参与者（最多5家）的详细分析和概况。

目录

第一章：产品概述

第二章：研究方法

第三章：COVID-19对全球长读测序市场的影响

第四章：客户的声音

第五章：执行摘要

第六章：全球长读测序市场前景

• 市场规模和预测
  • 按价值
• 市场份额与预测
  • 按组件（仪器、消耗品、服务）分类
  • 按技术分类（单分子实时测序（SMRT），纳米孔测序，其他）
  • 按工作流程（预测序、测序、数据分析）分类
  • 按应用（肿瘤、传染病、罕见病、遗传性疾病、代谢性疾病、其他）分类
  • 按终端用户（医院和诊所、生物技术和制药公司、学术和研究机构、其他）分类
  • 按地区分类
  • 按公司分类（2021年）
• 市场地图

第七章：北美长读测序市场前景

• 市场规模和预测
  • 按价值分类
• 市场份额与预测
  • 按组件分类
  • 按技术分类
  • 按工作流程分类
  • 按应用
  • 按终端用户
  • 按国家分类
• 北美洲：国家分析
  • 美国
  • 墨西哥
  • 加拿大

第8章：欧洲长读测序市场前景

• 市场规模和预测
  • 按价值计算
• 市场份额与预测
  • 按组件分类
  • 按技术分类
  • 按工作流程分类
  • 按应用
  • 按终端用户
  • 按国家分类
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 意大利
  • 西班牙

第九章：亚太地区长读测序市场前景

• 市场规模和预测
  • 按价值计算
• 市场份额与预测
  • 按组件分类
  • 按技术分类
  • 按工作流程分类
  • 按应用
  • 按终端用户
  • 按国家分类
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳大利亚

第十章：南美长读测序市场前景

• 市场规模和预测
  • 按价值计算
• 市场份额与预测
  • 按组件分类
  • 按技术分类
  • 按工作流程分类
  • 按应用
  • 按终端用户
  • 按国家分类
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第11章 ：中东和非洲长读测序市场前景

• 市场规模和预测
  • 按价值
• 市场份额与预测
  • 按组件分类
  • 按技术分类
  • 按工作流程分类
  • 按应用
  • 按终端用户
  • 按国家分类
• MEA: 国家分析
  • 南非长读测序
  • 沙特长读测序
  • 阿联酋 长读测序

第12章 ：市场动态

• 驱动力
• 挑战

第十三章 ：市场趋势与发展

第十四章：竞争格局

• Agilent Technologies, Inc.BGI Group Bionano Genomics, Inc.Circulomics Inc Oxford Nanopore Technologies plc Longas Technologies Pty Ltd Novogene Co.Illumina, Inc.F. Hoffmann-La Roche AG Pacific Biosciences of California, Inc.Quantapore, Inc.QIAGEN NV PerkinElmer, Inc Thermo Fischer Scientific, Inc.Takara Bio, Inc.

第十五章：战略建议

The global long-read sequencing market is anticipated to observe impressive growth during the forecast period 2023-2027. The major factors include growing occurrences of genetic disorders, growing government support for R&D activities, and extensive development in technology are fueling the growth of the market. Long-read sequencing, also known as third-generation sequencing, is a DNA sequencing technique that is being researched. It can determine the nucleotide sequence of long sequences of DNA ranging between 10,000 and 100,000 base pairs at a time. This technology eliminates the need to cut up and then amplify DNA which is usually needed in other DNA sequencing methods. The other factors supporting the market's growth are, a rise in R&D activities, a growing number of patients with genetic diseases, including cancer, an increasing number of clinical trials, the rising popularity of personalized medicine, increasing acceptance of modern approaches for medical diagnostics, rising utilization of sequence analysis methodologies in medical institutes for academic purposes, rise in world population, growing adoption of inorganic growth strategies, and immense potential for emerging submarkets.

The surge in Incidences of Genetic Disorders

The increasing prevalence of genetic diseases, such as color blindness, Down's syndrome, cystic fibrosis, and others, across the globe is bolstering the growth of the market. According to the World Health Organization (WHO), more than 10,000 of the diseases are known to be monogenic, triggered by a single error in a single gene in the human DNA. With the help of long-read sequencing methods, the whole genomics of the patient can be examined. Thus, rising the adoption of long-read sequencing in the treatment of genetic conditions. The growing number of patients suffering from genetic diseases is also a contributing factor to the growth of the market. According to the World Health Organization (WHO), sickle cell anemia, a severe genetic condition, affects about 72,000 newborn babies.

Increasing Government Support for R&D Activities

The increasing research which uses long-read sequencing methods is being heavily funded by government authorities, which is a key reason for the growth of the market. Moreover, the rising number of research activities is augmenting the growth of the market. For instance, in the U.S., genomics research and development projects are funded through the National Institutes of Health (NIH) as well as numerous other groups from around the globe. Presently, numerous amounts of research activities are being performed, which is projected to give manufacturers an advantage as they develop new and advanced long-read sequencing, as well as to open many opportunities in the long-read sequencing market. For instance, in the U.S., genomics research and development projects are funded through the National Institutes of Health (NIH) as well as numerous other groups from around the globe.

Technological advancements

The rise in technological advancements in sequencers is propelling the growth of the market. These advancements have made sequencing more efficient, accurate, and portable. For instance, long reads generated by SMRT sequencers span around possible repetitive regions and give a comprehensive view of the whole genome. Similarly, in 2018, Pacific Biosciences of California (PacBio) announced the enhancements to their Sequel System, which comprises a new version of its software, new consumables including reagents, and a new SMRT Cell (1M v3).

Market Segmentation

The global long-read sequencing market is segmented into components, technology, workflow, application, end user, and company. Based on components, the market is divided into instruments, consumables, and services. Based on technology, the market is divided into single-molecule real-time sequencing (SMRT), nanopore sequencing, and others. Based on workflow, the market is divided into pre-sequencing, sequencing, and data analysis. Based on application, the market is divided into oncology, infectious diseases, rare diseases, genetic disorders, metabolic disorders, and others. Based on end-user, the market is divided into hospitals & clinics, biotechnology & pharmaceutical companies, academic & research institutions, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to rising incidences of hematologic malignancies in the country.

Market Players

Agilent Technologies, Inc., BGI Group, Bionano Genomics, Inc., Circulomics Inc, Oxford Nanopore Technologies plc, Longas Technologies Pty Ltd, Novogene Co., Ltd., Illumina, Inc., F. Hoffmann-La Roche AG, Pacific Biosciences of California, Inc., Quantapore, Inc., QIAGEN NV, PerkinElmer, Inc, Thermo Fischer Scientific, Inc., and Takara Bio, Inc. are some of the leading companies operating in the market.

Report Scope

In this report, global long-read sequencing market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Long Read Sequencing Market, By Component:

• Instruments
• Consumables
• Services

Long Read Sequencing Market, By Technology:

• Single-Molecule Real-Time Sequencing (SMRT)
• Nanopore Sequencing
• Others

Long Read Sequencing Market, By Workflow:

• Pre-Sequencing
• Sequencing
• Data Analysis

Long Read Sequencing Market, By Application:

• Oncology
• Infectious Diseases
• Rare Diseases
• Genetic Disorders,
• Metabolic Disorders
• Others

Long Read Sequencing Market, By End User:

• Hospitals & Clinics
• Biotechnology & Pharmaceutical Companies,
• Academic & Research Institutions
• Others

Long Read Sequencing Market, By Region:

• North America
  • United States
  • Canada
  • Mexico

• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea

• Europe & CIS
  • Germany
  • France
  • United Kingdom
  • Spain
  • Italy

• South America
  • Brazil
  • Argentina
  • Colombia

• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Long Read Sequencing Market

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Long Read Sequencing Market

4. Voice of Customer

5. Executive Summary

6. Global Long Read Sequencing Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Component (Instruments, Consumables, Services)
  • 6.2.2. By Technology (Single-Molecule Real-Time Sequencing (SMRT), Nanopore Sequencing, Others)
  • 6.2.3. By Workflow (Pre-Sequencing, Sequencing, Data Analysis)
  • 6.2.4. By Application (Oncology, Infectious Diseases, Rare Diseases, Genetic Disorders, Metabolic Disorders, Others)
  • 6.2.5. By End User (Hospitals & Clinics, Biotechnology & Pharmaceutical Companies, Academic & Research Institutions, Others)
  • 6.2.6. By Region
  • 6.2.7. By Company (2021)
• 6.3. Market Map

7. North America Long Read Sequencing Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Component
  • 7.2.2. By Technology
  • 7.2.3. By Workflow
  • 7.2.4. By Application
  • 7.2.5. By End User
  • 7.2.6. By Country
• 7.3. North America: Country Analysis
  • 7.3.1. United States Long Read Sequencing Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Component
      • 7.3.1.2.2. By Technology
      • 7.3.1.2.3. By Workflow
      • 7.3.1.2.4. By Application
      • 7.3.1.2.5. By End User
  • 7.3.2. Mexico Long Read Sequencing Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Component
      • 7.3.2.2.2. By Technology
      • 7.3.2.2.3. By Workflow
      • 7.3.2.2.4. By Application
      • 7.3.2.2.5. By End User
  • 7.3.3. Canada Long Read Sequencing Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Component
      • 7.3.3.2.2. By Technology
      • 7.3.3.2.3. By Workflow
      • 7.3.3.2.4. By Application
      • 7.3.3.2.5. By End User

8. Europe Long Read Sequencing Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Component
  • 8.2.2. By Technology
  • 8.2.3. By Workflow
  • 8.2.4. By Application
  • 8.2.5. By End User
  • 8.2.6. By Country
• 8.3. Europe: Country Analysis
  • 8.3.1. France Long Read Sequencing Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Component
      • 8.3.1.2.2. By Technology
      • 8.3.1.2.3. By Workflow
      • 8.3.1.2.4. By Application
      • 8.3.1.2.5. By End User
  • 8.3.2. Germany Long Read Sequencing Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Component
      • 8.3.2.2.2. By Technology
      • 8.3.2.2.3. By Workflow
      • 8.3.2.2.4. By Application
      • 8.3.2.2.5. By End User
  • 8.3.3. United Kingdom Long Read Sequencing Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Component
      • 8.3.3.2.2. By Technology
      • 8.3.3.2.3. By Workflow
      • 8.3.3.2.4. By Application
      • 8.3.3.2.5. By End User
  • 8.3.4. Italy Long Read Sequencing Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Component
      • 8.3.4.2.2. By Technology
      • 8.3.4.2.3. By Workflow
      • 8.3.4.2.4. By Application
      • 8.3.4.2.5. By End User
  • 8.3.5. Spain Long Read Sequencing Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Component
      • 8.3.5.2.2. By Technology
      • 8.3.5.2.3. By Workflow
      • 8.3.5.2.4. By Application
      • 8.3.5.2.5. By End User

9. Asia-Pacific Long Read Sequencing Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Component
  • 9.2.2. By Technology
  • 9.2.3. By Workflow
  • 9.2.4. By Application
  • 9.2.5. By End User
  • 9.2.6. By Country
• 9.3. Asia-Pacific: Country Analysis
  • 9.3.1. China Long Read Sequencing Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Component
      • 9.3.1.2.2. By Technology
      • 9.3.1.2.3. By Workflow
      • 9.3.1.2.4. By Application
      • 9.3.1.2.5. By End User
  • 9.3.2. India Long Read Sequencing Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Component
      • 9.3.2.2.2. By Technology
      • 9.3.2.2.3. By Workflow
      • 9.3.2.2.4. By Application
      • 9.3.2.2.5. By End User
  • 9.3.3. Japan Long Read Sequencing Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Component
      • 9.3.3.2.2. By Technology
      • 9.3.3.2.3. By Workflow
      • 9.3.3.2.4. By Application
      • 9.3.3.2.5. By End User
  • 9.3.4. South Korea Long Read Sequencing Market Outlook
    • 9.3.4.1. Market Size & Forecast
      • 9.3.4.1.1. By Value
    • 9.3.4.2. Market Share & Forecast
      • 9.3.4.2.1. By Component
      • 9.3.4.2.2. By Technology
      • 9.3.4.2.3. By Workflow
      • 9.3.4.2.4. By Application
      • 9.3.4.2.5. By End User
  • 9.3.5. Australia Long Read Sequencing Market Outlook
    • 9.3.5.1. Market Size & Forecast
      • 9.3.5.1.1. By Value
    • 9.3.5.2. Market Share & Forecast
      • 9.3.5.2.1. By Component
      • 9.3.5.2.2. By Technology
      • 9.3.5.2.3. By Workflow
      • 9.3.5.2.4. By Application
      • 9.3.5.2.5. By End User

10. South America Long Read Sequencing Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Component
  • 10.2.2. By Technology
  • 10.2.3. By Workflow
  • 10.2.4. By Application
  • 10.2.5. By End User
  • 10.2.6. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Long Read Sequencing Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Component
      • 10.3.1.2.2. By Technology
      • 10.3.1.2.3. By Workflow
      • 10.3.1.2.4. By Application
      • 10.3.1.2.5. By End User
  • 10.3.2. Argentina Long Read Sequencing Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Component
      • 10.3.2.2.2. By Technology
      • 10.3.2.2.3. By Workflow
      • 10.3.2.2.4. By Application
      • 10.3.2.2.5. By End User
  • 10.3.3. Colombia Long Read Sequencing Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Component
      • 10.3.3.2.2. By Technology
      • 10.3.3.2.3. By Workflow
      • 10.3.3.2.4. By Application
      • 10.3.3.2.5. By End User

11. Middle East and Africa Long Read Sequencing Market Outlook

• 11.1. Market Size & Forecast
  • 11.1.1. By Value
• 11.2. Market Share & Forecast
  • 11.2.1. By Component
  • 11.2.2. By Technology
  • 11.2.3. By Workflow
  • 11.2.4. By Application
  • 11.2.5. By End User
  • 11.2.6. By Country
• 11.3. MEA: Country Analysis
  • 11.3.1. South Africa Long Read Sequencing Market Outlook
    • 11.3.1.1. Market Size & Forecast
      • 11.3.1.1.1. By Value
    • 11.3.1.2. Market Share & Forecast
      • 11.3.1.2.1. By Component
      • 11.3.1.2.2. By Technology
      • 11.3.1.2.3. By Workflow
      • 11.3.1.2.4. By Application
      • 11.3.1.2.5. By End User
  • 11.3.2. Saudi Arabia Long Read Sequencing Market Outlook
    • 11.3.2.1. Market Size & Forecast
      • 11.3.2.1.1. By Value
    • 11.3.2.2. Market Share & Forecast
      • 11.3.2.2.1. By Component
      • 11.3.2.2.2. By Technology
      • 11.3.2.2.3. By Workflow
      • 11.3.2.2.4. By Application
      • 11.3.2.2.5. By End User
  • 11.3.3. UAE Long Read Sequencing Market Outlook
    • 11.3.3.1. Market Size & Forecast
      • 11.3.3.1.1. By Value
    • 11.3.3.2. Market Share & Forecast
      • 11.3.3.2.1. By Component
      • 11.3.3.2.2. By Technology
      • 11.3.3.2.3. By Workflow
      • 11.3.3.2.4. By Application
      • 11.3.3.2.5. By End User

12. Market Dynamics

• 12.1. Drivers
• 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

• 14.1. Agilent Technologies, Inc.
• 14.2. BGI Group
• 14.3. Bionano Genomics, Inc.
• 14.4. Circulomics Inc
• 14.5. Oxford Nanopore Technologies plc
• 14.6. Longas Technologies Pty Ltd
• 14.7. Novogene Co., Ltd.
• 14.8. Illumina, Inc.
• 14.9. F. Hoffmann-La Roche AG
• 14.10. Pacific Biosciences of California, Inc.
• 14.11. Quantapore, Inc.
• 14.12. QIAGEN NV
• 14.13. PerkinElmer, Inc
• 14.14. Thermo Fischer Scientific, Inc.
• 14.15. Takara Bio, Inc.

15. Strategic Recommendations